Sector consensus Bolt Biotherapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 13/04/2026 BST			5-day change	1st Jan Change
4.660 ^USD	-5.09%		-5.48%	-14.78%

03-12	Bolt Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-11	Bolt Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
BOLT BIOTHERAPEUTICS, INC.			29	+522.32%	3
ARGENX SE			841.21	+24.26%	15
WUXI APPTEC CO., LTD.			134.62	+27.35%	18
INSMED INCORPORATED			212.15	+40.37%	20
BIONTECH SE			112.88	+36.65%	18
WUXI BIOLOGICS (CAYMAN) INC.			40.19	+30.62%	21
GENMAB A/S			2,232.52	+24.34%	14
AKESO, INC.			151.89	+26.39%	20
SUMMIT THERAPEUTICS INC.			22.9	+51.48%	14
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.			533.22	+9.45%	17
MADRIGAL PHARMACEUTICALS, INC.			668.57	+27.18%	14
EXELIXIS, INC.			46.83	+4.17%	18
REMEGEN CO., LTD.			97.1	+1.36%	15
SAMSUNG EPIS HOLDINGS CO., LTD.	-	-	770,000	+42.86%	1
ARROWHEAD PHARMACEUTICALS, INC.			81.09	+27.12%	11
VAXCYTE, INC.			109	+76.52%	9
CYTOKINETICS, INCORPORATED			92.94	+39.31%	18
NUVALENT, INC.			142.39	+37.32%	18
PHARMAESSENTIA CORPORATION			757	+17%	7
IMMUNITYBIO, INC.			14.8	+102.74%	5
Average			38,816.02	+58.44%	14
Weighted average by Cap.			21,584.39	+31.35%	16